Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 586 results for "drl"

Dr Reddy's Labs to market Gland Pharma's eight injectable ANDA...

Dr Reddy's Laboratories (DRL) has entered into a strategic collaboration with Gland Pharma, a globally recognized developer and manufacturer of sterile dosage forms, to market and distribute a diverse portfolio of eight injectable ANDAs. The ... PharmaBiz, 1 month ago
DRL in pact with Gland Pharma in the US market Express Pharma, 1 month ago

96 images for drl

Before It's News, 6 days ago
USA Today, 1 week ago
USA Today, 1 week ago
Before It's News, 2 weeks ago
sUAS News, 3 weeks ago
USA Today, 2 weeks ago
Sify, 3 weeks ago
USA Today, 1 month ago
Deccan Chronicle, 1 month ago
USA Today, 1 month ago
Deccan Chronicle

Buy Dr Reddy's Laboratories, Maruti Suzuki: Rajat Bose

Rajat Bose of told CNBC-TV18, " Dr Reddy's Laboratories and Maruti Suzuki are the two buy calls I have. DRL and Maruti have been performing lately pretty well and yesterday they did pretty well in the last couple of hours and today ...
 Moneycontrol.com1 month ago DRL profits sink 60 per cent in quarter 2  Deccan Chronicle1 month ago Poor sales in North America plunge Dr Reddy's Q2 profit; down 60% to Rs 31 cr  Business Standard1 month ago DRL inks pact with US-based Amgen to market three drugs in India  First Post.com2 months ago

DRL announces launch of Raloxifene HCl Tablets in the US market

Dr Reddy's Laboratories has launched of Raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets in the United States market, approved by the US Food & Drug Administration (US ...
 CPhI.cn3 weeks ago DRL launches Raloxifene HCl tablets in US  Times of India3 weeks ago Dr Reddy’s launches generic injection for kidney disease  Business Line2 months ago
sUAS News

Download of the day: DRL Drone Racing Simulator

Competitive drone racing is a burgeoning sport, with serious prize money up for grabs. Racing drones themselves are reasonably priced at around £300 (US$400, AU$550), but to stand a chance in a stadium you'll need to hone your skills - and even an ...
 Techradar India2 weeks ago Drone Racing Simulators  Trend Hunter3 weeks ago Drone Racing League: Fire City on Sky Sports Mix  Sky Sports3 weeks ago Drone Racing League and Bud, only if you are American and older than 21  sUAS News3 weeks ago

Sensex regains most of lost ground; DRL, Sun Pharma, SBI up sharply

The market has come back strongly from dismal levels, thanks to some hectic buying in pharmaceuticals and bank stocks this afternoon, despite weakness in global markets. Prospects of Donald Trump's win and the demonetisation of 500 and 1000 rupee notes by the ...
 Sify3 weeks ago Sensex falls 63 points; Sun Pharma, DRL drag  Myiris1 month ago

DRL launches lamotrigine orally disintegrating tablets in US

The therapeutic equivalent generic version of Lamictal ODT is available in 25 mg, 50 mg, 100 mg, and 200 mg Dr Reddy's Laboratories (DRL) has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg, and 200 mg, a therapeutic ...
 Express Pharma1 month ago DRL launches of Aripiprazole tablets in the US  Express Pharma1 month ago

Sensex recovers, Nifty firm above 8600; Tata Motors, DRL lead

Equity benchmarks recovered early losses with the Nifty rising over 8600 level on first day of November series. Select Tata Group stocks like Tata Motors and Tata Steel rebounded sharply on short covering after sharp sell-off in previous three consecutive ...
 Money Control1 month ago

DRL posts Q2 FY17 and H1FY17 results

In Q2 FY17, EBITDA is at Rs 6.4 billion and profit after tax at Rs 2.9 billion Dr Reddy's Laboratories (DRL) announced its consolidated financial results for the second quarter and half year ended September 30, 2016 under International Financial ...
 Express Pharma1 month ago

Dr Reddy's net dips by over 60% in Q2 to Rs. 309 cr

Dr Reddy's Laboratories (DRL), a second largest Indian pharma giant with net sales of Rs. 15,248 crore, has suffered heavy setback during the second quarter ended September 2016 due to US warning letter, currency devaluation and dismissal of writ ...
 PharmaBiz1 month ago Dr. Reddy's Laboratories record decline of 60.12% in second quarter  Equilibrio Informativo1 month ago
Money Control

DRL Q2 in line with view, coming qtrs may not be great: experts

The earning numbers a mostly in line with estimates and Angel Broking keeps a neutral rating on the stock, says Sarabjit Kour Nangra of Angel Broking.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less